Cite
HARVARD Citation
Tataroglu Ozyukseler, D. et al. (2021). Prognostic factors of ado-trastuzumab emtansine treatment in patients with metastatic HER-2 positive breast cancer. Journal of oncology pharmacy practice. pp. 547-554. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Tataroglu Ozyukseler, D. et al. (2021). Prognostic factors of ado-trastuzumab emtansine treatment in patients with metastatic HER-2 positive breast cancer. Journal of oncology pharmacy practice. pp. 547-554. [Online].